Intraoperative Dexamethasone and Its Effect on Hyperglycemia
NCT03646916 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2021-01-22
Summary
To study the effect of intra-operative dexamethasone on the management of post-operative blood sugar in diabetic patients.
Conditions
Interventions
- DRUG
-
Gluco-corticosteroid
- OTHER
-
No dexamethasone
Nothing
Sponsors & Collaborators
-
Ascension Health
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-15
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NCT04965051 ·Status: UNKNOWN ·Phase: NA
-
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.
NCT07224334 ·Status: RECRUITING ·Phase: PHASE1
-
Inpatient Diabetes on Corticosteroids
NCT01970241 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Short Course of Glucocorticoid in Patients With Diabetes Mellitus(DM) Type 2
NCT03661684 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver
NCT01986231 ·Status: COMPLETED ·Phase: NA
-
Metformin to Treat Corticosteroids-induced Hyperglycemia
NCT04332393 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)
NCT05139316 ·Status: COMPLETED ·Phase: PHASE3
-
Glucotoxicity and Acute Exercise
NCT01771614 ·Status: WITHDRAWN ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism
NCT04300049 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135 ·Status: COMPLETED ·Phase: NA
-
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
NCT00351234 ·Status: COMPLETED
-
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
NCT03685773 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Prebiotics on GLP-1 in Type 2 Diabetes
NCT02569684 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes
NCT06424106 ·Status: RECRUITING ·Phase: NA
-
GLP 1 for Intraoperative Glycemic Control
NCT00882492 ·Status: COMPLETED ·Phase: PHASE1
-
Duodenal Exclusion for the Treatment of Type 2 Diabetes
NCT00534547 ·Status: WITHDRAWN ·Phase: NA
-
Metformin to Prevent Metabolic Complications in Glucocorticoid Excess
NCT01187849 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
NCT02077348 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults
NCT04824872 ·Status: WITHDRAWN ·Phase: PHASE2
-
Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
NCT05076292 ·Status: COMPLETED ·Phase: NA
-
The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
NCT04472962 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes
NCT04956263 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
NCT03356457 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
NCT00004419 ·Status: COMPLETED ·Phase: NA